Shares of ResMed have moved -0.9% today, and are now trading at a price of $234.09. In contrast, the S&P 500 index saw a 1.0% change. Today's trading volume is 739,249 compared to the stock's average volume of 1,145,932.
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company is now trading -11.04% away from its average analyst target price of $263.15 per share. The 15 analysts following the stock have set target prices ranging from $200.0 to $295.0, and on average give ResMed a rating of buy.
Over the last 52 weeks, RMD stock has risen 8.3%, which amounts to a 0.7% difference compared to the S&P 500. The stock's 52 week high is $263.05 whereas its 52 week low is $179.42 per share. Based on ResMed's average net margin growth of 5.3% over the last 6 years, its core business is on track for profitability and its strong stock performance may continue in the long term.
| Date Reported | Total Revenue ($ k) | Net Profit ($ k) | Net Margins (%) | YoY Growth (%) |
|---|---|---|---|---|
| 2024 | 4,685,297 | 1,020,951 | 22 | 4.76 |
| 2023 | 4,222,993 | 897,556 | 21 | -4.55 |
| 2022 | 3,578,127 | 779,437 | 22 | 46.67 |
| 2021 | 3,196,825 | 474,505 | 15 | -28.57 |
| 2020 | 2,957,013 | 621,674 | 21 | 31.25 |
| 2019 | 2,606,572 | 404,592 | 16 |
